nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—pancreatic cancer—liver cancer	0.273	0.378	CtDrD
Gemcitabine—kidney cancer—liver cancer	0.229	0.317	CtDrD
Gemcitabine—lung cancer—liver cancer	0.22	0.305	CtDrD
Gemcitabine—ABCC10—Doxorubicin—liver cancer	0.0762	0.802	CbGbCtD
Gemcitabine—ABCB1—Sorafenib—liver cancer	0.0117	0.123	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—liver cancer	0.0071	0.0747	CbGbCtD
Gemcitabine—POLE—embryo—liver cancer	0.000861	0.121	CbGeAlD
Gemcitabine—SLC28A1—liver—liver cancer	0.0008	0.112	CbGeAlD
Gemcitabine—DCK—Doxorubicin—Epirubicin—liver cancer	0.000786	0.519	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—liver cancer	0.000727	0.481	CbGdCrCtD
Gemcitabine—RRM2—embryo—liver cancer	0.000709	0.0996	CbGeAlD
Gemcitabine—POLD1—liver—liver cancer	0.000533	0.0748	CbGeAlD
Gemcitabine—CDA—liver—liver cancer	0.000478	0.0672	CbGeAlD
Gemcitabine—DCK—embryo—liver cancer	0.000458	0.0643	CbGeAlD
Gemcitabine—SLC29A2—liver—liver cancer	0.000447	0.0628	CbGeAlD
Gemcitabine—CMPK1—liver—liver cancer	0.000425	0.0597	CbGeAlD
Gemcitabine—POLE—liver—liver cancer	0.000398	0.056	CbGeAlD
Gemcitabine—POLA1—liver—liver cancer	0.000343	0.0482	CbGeAlD
Gemcitabine—RRM2—liver—liver cancer	0.000328	0.0461	CbGeAlD
Gemcitabine—Angiopathy—Sorafenib—liver cancer	0.000285	0.00288	CcSEcCtD
Gemcitabine—Immune system disorder—Sorafenib—liver cancer	0.000284	0.00287	CcSEcCtD
Gemcitabine—Mediastinal disorder—Sorafenib—liver cancer	0.000283	0.00286	CcSEcCtD
Gemcitabine—Petechiae—Epirubicin—liver cancer	0.000281	0.00284	CcSEcCtD
Gemcitabine—Arrhythmia—Sorafenib—liver cancer	0.00028	0.00284	CcSEcCtD
Gemcitabine—Pleural effusion—Doxorubicin—liver cancer	0.000279	0.00282	CcSEcCtD
Gemcitabine—Alopecia—Sorafenib—liver cancer	0.000277	0.00281	CcSEcCtD
Gemcitabine—Erythema—Sorafenib—liver cancer	0.000273	0.00276	CcSEcCtD
Gemcitabine—RRM1—liver—liver cancer	0.000273	0.0383	CbGeAlD
Gemcitabine—Neoplasm malignant—Epirubicin—liver cancer	0.000271	0.00274	CcSEcCtD
Gemcitabine—Extravasation—Epirubicin—liver cancer	0.000265	0.00268	CcSEcCtD
Gemcitabine—Petechiae—Doxorubicin—liver cancer	0.00026	0.00263	CcSEcCtD
Gemcitabine—Bone disorder—Epirubicin—liver cancer	0.000256	0.00259	CcSEcCtD
Gemcitabine—Cellulitis—Epirubicin—liver cancer	0.000254	0.00257	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000254	0.00257	CcSEcCtD
Gemcitabine—Anaemia—Sorafenib—liver cancer	0.000253	0.00255	CcSEcCtD
Gemcitabine—Hypocalcaemia—Epirubicin—liver cancer	0.000252	0.00255	CcSEcCtD
Gemcitabine—Neoplasm malignant—Doxorubicin—liver cancer	0.00025	0.00253	CcSEcCtD
Gemcitabine—TYMS—liver—liver cancer	0.000247	0.0347	CbGeAlD
Gemcitabine—Extravasation—Doxorubicin—liver cancer	0.000245	0.00248	CcSEcCtD
Gemcitabine—Leukopenia—Sorafenib—liver cancer	0.000245	0.00247	CcSEcCtD
Gemcitabine—Ulcer—Epirubicin—liver cancer	0.000244	0.00247	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Epirubicin—liver cancer	0.000244	0.00247	CcSEcCtD
Gemcitabine—Creatinine increased—Epirubicin—liver cancer	0.000243	0.00245	CcSEcCtD
Gemcitabine—Bone pain—Epirubicin—liver cancer	0.000241	0.00244	CcSEcCtD
Gemcitabine—Cough—Sorafenib—liver cancer	0.000238	0.00241	CcSEcCtD
Gemcitabine—Bone disorder—Doxorubicin—liver cancer	0.000237	0.00239	CcSEcCtD
Gemcitabine—Hypertension—Sorafenib—liver cancer	0.000236	0.00239	CcSEcCtD
Gemcitabine—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.000235	0.00238	CcSEcCtD
Gemcitabine—Cellulitis—Doxorubicin—liver cancer	0.000235	0.00238	CcSEcCtD
Gemcitabine—Hypocalcaemia—Doxorubicin—liver cancer	0.000233	0.00236	CcSEcCtD
Gemcitabine—Arthralgia—Sorafenib—liver cancer	0.000233	0.00235	CcSEcCtD
Gemcitabine—Myalgia—Sorafenib—liver cancer	0.000233	0.00235	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000231	0.00234	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Epirubicin—liver cancer	0.000231	0.00234	CcSEcCtD
Gemcitabine—Injection site reaction—Epirubicin—liver cancer	0.00023	0.00232	CcSEcCtD
Gemcitabine—Blood bilirubin increased—Doxorubicin—liver cancer	0.000226	0.00229	CcSEcCtD
Gemcitabine—Ulcer—Doxorubicin—liver cancer	0.000226	0.00229	CcSEcCtD
Gemcitabine—Creatinine increased—Doxorubicin—liver cancer	0.000225	0.00227	CcSEcCtD
Gemcitabine—Influenza like illness—Epirubicin—liver cancer	0.000224	0.00227	CcSEcCtD
Gemcitabine—Bone pain—Doxorubicin—liver cancer	0.000223	0.00226	CcSEcCtD
Gemcitabine—Anaphylactic shock—Sorafenib—liver cancer	0.000223	0.00226	CcSEcCtD
Gemcitabine—SLC29A1—liver—liver cancer	0.000222	0.0311	CbGeAlD
Gemcitabine—Infection—Sorafenib—liver cancer	0.000222	0.00224	CcSEcCtD
Gemcitabine—Skin exfoliation—Epirubicin—liver cancer	0.000221	0.00223	CcSEcCtD
Gemcitabine—Fluid retention—Epirubicin—liver cancer	0.000219	0.00222	CcSEcCtD
Gemcitabine—Nervous system disorder—Sorafenib—liver cancer	0.000219	0.00221	CcSEcCtD
Gemcitabine—Thrombocytopenia—Sorafenib—liver cancer	0.000218	0.00221	CcSEcCtD
Gemcitabine—Blood urea increased—Epirubicin—liver cancer	0.000218	0.00221	CcSEcCtD
Gemcitabine—Neuropathy—Epirubicin—liver cancer	0.000217	0.00219	CcSEcCtD
Gemcitabine—Skin disorder—Sorafenib—liver cancer	0.000217	0.00219	CcSEcCtD
Gemcitabine—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.000214	0.00216	CcSEcCtD
Gemcitabine—Anorexia—Sorafenib—liver cancer	0.000213	0.00215	CcSEcCtD
Gemcitabine—Injection site reaction—Doxorubicin—liver cancer	0.000212	0.00215	CcSEcCtD
Gemcitabine—DCK—liver—liver cancer	0.000212	0.0297	CbGeAlD
Gemcitabine—Influenza like illness—Doxorubicin—liver cancer	0.000208	0.0021	CcSEcCtD
Gemcitabine—Pulmonary oedema—Epirubicin—liver cancer	0.000206	0.00208	CcSEcCtD
Gemcitabine—Skin exfoliation—Doxorubicin—liver cancer	0.000204	0.00206	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000203	0.00206	CcSEcCtD
Gemcitabine—Fluid retention—Doxorubicin—liver cancer	0.000203	0.00205	CcSEcCtD
Gemcitabine—Blood urea increased—Doxorubicin—liver cancer	0.000202	0.00204	CcSEcCtD
Gemcitabine—ABCC10—liver—liver cancer	0.000202	0.0283	CbGeAlD
Gemcitabine—Neuropathy—Doxorubicin—liver cancer	0.000201	0.00203	CcSEcCtD
Gemcitabine—Sepsis—Epirubicin—liver cancer	0.0002	0.00203	CcSEcCtD
Gemcitabine—Dyspnoea—Sorafenib—liver cancer	0.000199	0.00201	CcSEcCtD
Gemcitabine—Decreased appetite—Sorafenib—liver cancer	0.000194	0.00196	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000193	0.00195	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000193	0.00195	CcSEcCtD
Gemcitabine—Fatigue—Sorafenib—liver cancer	0.000192	0.00194	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Epirubicin—liver cancer	0.000192	0.00194	CcSEcCtD
Gemcitabine—Pain—Sorafenib—liver cancer	0.000191	0.00193	CcSEcCtD
Gemcitabine—Constipation—Sorafenib—liver cancer	0.000191	0.00193	CcSEcCtD
Gemcitabine—Pulmonary oedema—Doxorubicin—liver cancer	0.00019	0.00192	CcSEcCtD
Gemcitabine—Hepatic failure—Epirubicin—liver cancer	0.000187	0.00189	CcSEcCtD
Gemcitabine—Sepsis—Doxorubicin—liver cancer	0.000185	0.00188	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Epirubicin—liver cancer	0.000185	0.00187	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000178	0.0018	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Doxorubicin—liver cancer	0.000178	0.0018	CcSEcCtD
Gemcitabine—Body temperature increased—Sorafenib—liver cancer	0.000176	0.00178	CcSEcCtD
Gemcitabine—Renal impairment—Epirubicin—liver cancer	0.000176	0.00178	CcSEcCtD
Gemcitabine—Dermatitis bullous—Epirubicin—liver cancer	0.000175	0.00177	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Epirubicin—liver cancer	0.000173	0.00175	CcSEcCtD
Gemcitabine—Hepatic failure—Doxorubicin—liver cancer	0.000173	0.00175	CcSEcCtD
Gemcitabine—Cardiac failure—Epirubicin—liver cancer	0.000172	0.00174	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Epirubicin—liver cancer	0.000171	0.00173	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000171	0.00173	CcSEcCtD
Gemcitabine—Renal impairment—Doxorubicin—liver cancer	0.000163	0.00165	CcSEcCtD
Gemcitabine—Dermatitis bullous—Doxorubicin—liver cancer	0.000162	0.00164	CcSEcCtD
Gemcitabine—Face oedema—Epirubicin—liver cancer	0.000162	0.00164	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00016	0.00162	CcSEcCtD
Gemcitabine—Asthenia—Sorafenib—liver cancer	0.00016	0.00162	CcSEcCtD
Gemcitabine—Cardiac failure—Doxorubicin—liver cancer	0.000159	0.00161	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000158	0.0016	CcSEcCtD
Gemcitabine—Pruritus—Sorafenib—liver cancer	0.000158	0.0016	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—liver cancer	0.000157	0.00159	CcSEcCtD
Gemcitabine—Liver function test abnormal—Epirubicin—liver cancer	0.000155	0.00157	CcSEcCtD
Gemcitabine—Hypokalaemia—Epirubicin—liver cancer	0.000153	0.00154	CcSEcCtD
Gemcitabine—Diarrhoea—Sorafenib—liver cancer	0.000153	0.00154	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000151	0.00153	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000151	0.00153	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—liver cancer	0.00015	0.00152	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000148	0.0015	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—liver cancer	0.000145	0.00147	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—liver cancer	0.000145	0.00147	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—liver cancer	0.000143	0.00145	CcSEcCtD
Gemcitabine—Vomiting—Sorafenib—liver cancer	0.000142	0.00143	CcSEcCtD
Gemcitabine—Hypokalaemia—Doxorubicin—liver cancer	0.000141	0.00143	CcSEcCtD
Gemcitabine—Rash—Sorafenib—liver cancer	0.000141	0.00142	CcSEcCtD
Gemcitabine—Dermatitis—Sorafenib—liver cancer	0.00014	0.00142	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00014	0.00141	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00014	0.00141	CcSEcCtD
Gemcitabine—Headache—Sorafenib—liver cancer	0.00014	0.00141	CcSEcCtD
Gemcitabine—Pancytopenia—Epirubicin—liver cancer	0.000138	0.00139	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000137	0.00138	CcSEcCtD
Gemcitabine—Neutropenia—Epirubicin—liver cancer	0.000136	0.00137	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—liver cancer	0.000134	0.00136	CcSEcCtD
Gemcitabine—Nausea—Sorafenib—liver cancer	0.000132	0.00134	CcSEcCtD
Gemcitabine—Hyperglycaemia—Epirubicin—liver cancer	0.000131	0.00132	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—liver cancer	0.00013	0.00131	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000128	0.0013	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—liver cancer	0.000127	0.00129	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—liver cancer	0.000127	0.00128	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—liver cancer	0.000127	0.00128	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—liver cancer	0.000126	0.00127	CcSEcCtD
Gemcitabine—ABCB1—embryo—liver cancer	0.000126	0.0177	CbGeAlD
Gemcitabine—Neutropenia—Doxorubicin—liver cancer	0.000125	0.00127	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—liver cancer	0.000124	0.00125	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—liver cancer	0.000123	0.00125	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—liver cancer	0.000122	0.00124	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—liver cancer	0.000121	0.00122	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—liver cancer	0.000121	0.00122	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—liver cancer	0.00012	0.00122	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000119	0.0012	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—liver cancer	0.000118	0.00119	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000117	0.00119	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—liver cancer	0.000117	0.00118	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—liver cancer	0.000117	0.00118	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—liver cancer	0.000116	0.00118	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—liver cancer	0.000116	0.00117	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—liver cancer	0.000115	0.00116	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—liver cancer	0.000115	0.00116	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—liver cancer	0.000115	0.00116	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—liver cancer	0.000114	0.00116	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—liver cancer	0.000114	0.00115	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—liver cancer	0.000114	0.00115	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—liver cancer	0.000114	0.00115	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000113	0.00114	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—liver cancer	0.000112	0.00113	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—liver cancer	0.00011	0.00111	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—liver cancer	0.000108	0.00109	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—liver cancer	0.000108	0.00109	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—liver cancer	0.000108	0.00109	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—liver cancer	0.000107	0.00109	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—liver cancer	0.000107	0.00108	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—liver cancer	0.000106	0.00107	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—liver cancer	0.000106	0.00107	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—liver cancer	0.000105	0.00107	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—liver cancer	0.000105	0.00106	CcSEcCtD
Gemcitabine—Chills—Epirubicin—liver cancer	0.000104	0.00105	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—liver cancer	0.000104	0.00105	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—liver cancer	0.000103	0.00104	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—liver cancer	0.000101	0.00103	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—liver cancer	0.000101	0.00102	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—liver cancer	9.96e-05	0.00101	CcSEcCtD
Gemcitabine—Back pain—Epirubicin—liver cancer	9.77e-05	0.000988	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—liver cancer	9.74e-05	0.000985	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—liver cancer	9.69e-05	0.000981	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—liver cancer	9.67e-05	0.000978	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—liver cancer	9.63e-05	0.000974	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—liver cancer	9.59e-05	0.00097	CcSEcCtD
Gemcitabine—Alopecia—Doxorubicin—liver cancer	9.48e-05	0.000959	CcSEcCtD
Gemcitabine—Ill-defined disorder—Epirubicin—liver cancer	9.37e-05	0.000948	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—liver cancer	9.34e-05	0.000945	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—liver cancer	9.33e-05	0.000944	CcSEcCtD
Gemcitabine—Malaise—Epirubicin—liver cancer	9.11e-05	0.000921	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—liver cancer	9.04e-05	0.000914	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—liver cancer	9.04e-05	0.000914	CcSEcCtD
Gemcitabine—Cough—Epirubicin—liver cancer	8.81e-05	0.000891	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—liver cancer	8.72e-05	0.000882	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—liver cancer	8.67e-05	0.000877	CcSEcCtD
Gemcitabine—Anaemia—Doxorubicin—liver cancer	8.64e-05	0.000874	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—liver cancer	8.6e-05	0.00087	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—liver cancer	8.6e-05	0.00087	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—liver cancer	8.6e-05	0.00087	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	8.54e-05	0.000864	CcSEcCtD
Gemcitabine—Discomfort—Epirubicin—liver cancer	8.49e-05	0.000859	CcSEcCtD
Gemcitabine—Malaise—Doxorubicin—liver cancer	8.43e-05	0.000852	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—liver cancer	8.36e-05	0.000846	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—liver cancer	8.24e-05	0.000834	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—liver cancer	8.24e-05	0.000834	CcSEcCtD
Gemcitabine—Infection—Epirubicin—liver cancer	8.19e-05	0.000828	CcSEcCtD
Gemcitabine—Cough—Doxorubicin—liver cancer	8.15e-05	0.000825	CcSEcCtD
Gemcitabine—Nervous system disorder—Epirubicin—liver cancer	8.08e-05	0.000818	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—liver cancer	8.07e-05	0.000816	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—liver cancer	8.07e-05	0.000816	CcSEcCtD
Gemcitabine—Skin disorder—Epirubicin—liver cancer	8.01e-05	0.00081	CcSEcCtD
Gemcitabine—Hyperhidrosis—Epirubicin—liver cancer	7.97e-05	0.000806	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—liver cancer	7.95e-05	0.000805	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—liver cancer	7.95e-05	0.000805	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—liver cancer	7.95e-05	0.000805	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	7.9e-05	0.000799	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—liver cancer	7.86e-05	0.000795	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—liver cancer	7.86e-05	0.000795	CcSEcCtD
Gemcitabine—Hypotension—Epirubicin—liver cancer	7.7e-05	0.000779	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—liver cancer	7.63e-05	0.000771	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—liver cancer	7.63e-05	0.000771	CcSEcCtD
Gemcitabine—Infection—Doxorubicin—liver cancer	7.58e-05	0.000766	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—liver cancer	7.51e-05	0.00076	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—liver cancer	7.48e-05	0.000756	CcSEcCtD
Gemcitabine—Thrombocytopenia—Doxorubicin—liver cancer	7.47e-05	0.000755	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—liver cancer	7.45e-05	0.000754	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—liver cancer	7.41e-05	0.000749	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—liver cancer	7.4e-05	0.000749	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—liver cancer	7.37e-05	0.000746	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—liver cancer	7.35e-05	0.000743	CcSEcCtD
Gemcitabine—Somnolence—Epirubicin—liver cancer	7.33e-05	0.000741	CcSEcCtD
Gemcitabine—Anorexia—Doxorubicin—liver cancer	7.27e-05	0.000735	CcSEcCtD
Gemcitabine—Decreased appetite—Epirubicin—liver cancer	7.16e-05	0.000725	CcSEcCtD
Gemcitabine—Hypotension—Doxorubicin—liver cancer	7.13e-05	0.000721	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—liver cancer	7.12e-05	0.00072	CcSEcCtD
Gemcitabine—Fatigue—Epirubicin—liver cancer	7.11e-05	0.000719	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—liver cancer	7.05e-05	0.000713	CcSEcCtD
Gemcitabine—Pain—Epirubicin—liver cancer	7.05e-05	0.000713	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—liver cancer	6.95e-05	0.000703	CcSEcCtD
Gemcitabine—Insomnia—Doxorubicin—liver cancer	6.9e-05	0.000698	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—liver cancer	6.85e-05	0.000693	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—liver cancer	6.8e-05	0.000688	CcSEcCtD
Gemcitabine—Feeling abnormal—Epirubicin—liver cancer	6.79e-05	0.000687	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—liver cancer	6.78e-05	0.000686	CcSEcCtD
Gemcitabine—Decreased appetite—Doxorubicin—liver cancer	6.63e-05	0.000671	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—liver cancer	6.58e-05	0.000666	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—liver cancer	6.57e-05	0.000665	CcSEcCtD
Gemcitabine—Pain—Doxorubicin—liver cancer	6.52e-05	0.00066	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—liver cancer	6.52e-05	0.00066	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—liver cancer	6.51e-05	0.000659	CcSEcCtD
Gemcitabine—Feeling abnormal—Doxorubicin—liver cancer	6.28e-05	0.000636	CcSEcCtD
Gemcitabine—Body temperature increased—Doxorubicin—liver cancer	6.03e-05	0.00061	CcSEcCtD
Gemcitabine—Asthenia—Epirubicin—liver cancer	5.91e-05	0.000598	CcSEcCtD
Gemcitabine—Pruritus—Epirubicin—liver cancer	5.83e-05	0.00059	CcSEcCtD
Gemcitabine—ABCB1—liver—liver cancer	5.82e-05	0.00818	CbGeAlD
Gemcitabine—Diarrhoea—Epirubicin—liver cancer	5.64e-05	0.00057	CcSEcCtD
Gemcitabine—Asthenia—Doxorubicin—liver cancer	5.47e-05	0.000553	CcSEcCtD
Gemcitabine—Pruritus—Doxorubicin—liver cancer	5.4e-05	0.000546	CcSEcCtD
Gemcitabine—Vomiting—Epirubicin—liver cancer	5.24e-05	0.00053	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—liver cancer	5.22e-05	0.000528	CcSEcCtD
Gemcitabine—Rash—Epirubicin—liver cancer	5.2e-05	0.000526	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—liver cancer	5.19e-05	0.000525	CcSEcCtD
Gemcitabine—Headache—Epirubicin—liver cancer	5.16e-05	0.000522	CcSEcCtD
Gemcitabine—Nausea—Epirubicin—liver cancer	4.9e-05	0.000495	CcSEcCtD
Gemcitabine—Vomiting—Doxorubicin—liver cancer	4.85e-05	0.00049	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—liver cancer	4.81e-05	0.000486	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—liver cancer	4.8e-05	0.000486	CcSEcCtD
Gemcitabine—Headache—Doxorubicin—liver cancer	4.78e-05	0.000483	CcSEcCtD
Gemcitabine—Nausea—Doxorubicin—liver cancer	4.53e-05	0.000458	CcSEcCtD
Gemcitabine—POLD1—Metabolism—PSMD10—liver cancer	2.42e-05	0.000321	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTA4—liver cancer	2.41e-05	0.000319	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—liver cancer	2.39e-05	0.000317	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GOT2—liver cancer	2.37e-05	0.000314	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—liver cancer	2.37e-05	0.000314	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—liver cancer	2.37e-05	0.000314	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.36e-05	0.000313	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GOT2—liver cancer	2.35e-05	0.000312	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—liver cancer	2.35e-05	0.000312	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PCNA—liver cancer	2.35e-05	0.000311	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTA2—liver cancer	2.35e-05	0.000311	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.35e-05	0.000311	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARA—liver cancer	2.34e-05	0.000311	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.34e-05	0.000311	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—RAF1—liver cancer	2.33e-05	0.000309	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.33e-05	0.000309	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSMA4—liver cancer	2.27e-05	0.000302	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PSMD10—liver cancer	2.27e-05	0.000302	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—liver cancer	2.27e-05	0.000301	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—liver cancer	2.27e-05	0.000301	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTA1—liver cancer	2.26e-05	0.0003	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.26e-05	0.0003	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—liver cancer	2.25e-05	0.000298	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.24e-05	0.000298	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NAT2—liver cancer	2.24e-05	0.000297	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND1—liver cancer	2.24e-05	0.000297	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTP1—liver cancer	2.23e-05	0.000296	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP2E1—liver cancer	2.23e-05	0.000295	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	2.23e-05	0.000295	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND1—liver cancer	2.22e-05	0.000295	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP2E1—liver cancer	2.21e-05	0.000293	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GOT2—liver cancer	2.21e-05	0.000293	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—HMOX1—liver cancer	2.2e-05	0.000292	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	2.18e-05	0.000289	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.16e-05	0.000287	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.15e-05	0.000285	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.15e-05	0.000285	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND1—liver cancer	2.15e-05	0.000285	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALDOB—liver cancer	2.15e-05	0.000285	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—liver cancer	2.1e-05	0.000278	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—liver cancer	2.08e-05	0.000276	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYCS—liver cancer	2.08e-05	0.000276	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.08e-05	0.000276	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP2E1—liver cancer	2.08e-05	0.000276	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1A—liver cancer	2.08e-05	0.000275	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYCS—liver cancer	2.07e-05	0.000275	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.06e-05	0.000273	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—liver cancer	2.05e-05	0.000272	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CRABP1—liver cancer	2.05e-05	0.000271	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GGT1—liver cancer	2.04e-05	0.000271	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GOT1—liver cancer	2.04e-05	0.000271	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	2.04e-05	0.00027	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GOT1—liver cancer	2.03e-05	0.000269	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GGT1—liver cancer	2.03e-05	0.000269	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—liver cancer	2.01e-05	0.000267	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CG—liver cancer	2.01e-05	0.000266	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND1—liver cancer	2e-05	0.000265	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	1.99e-05	0.000264	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND1—liver cancer	1.99e-05	0.000264	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	1.95e-05	0.000259	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYCS—liver cancer	1.95e-05	0.000258	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	1.95e-05	0.000258	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CASP3—liver cancer	1.95e-05	0.000258	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL2—liver cancer	1.94e-05	0.000258	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1A1—liver cancer	1.94e-05	0.000258	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PPARG—liver cancer	1.94e-05	0.000257	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1A—liver cancer	1.94e-05	0.000257	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1A—liver cancer	1.92e-05	0.000255	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND1—liver cancer	1.92e-05	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—liver cancer	1.91e-05	0.000254	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GGT1—liver cancer	1.91e-05	0.000253	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GOT1—liver cancer	1.91e-05	0.000253	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	1.91e-05	0.000253	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	1.87e-05	0.000247	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	1.87e-05	0.000247	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1A—liver cancer	1.86e-05	0.000246	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTP1—liver cancer	1.84e-05	0.000243	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTP1—liver cancer	1.82e-05	0.000242	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—liver cancer	1.81e-05	0.00024	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—HMOX1—liver cancer	1.81e-05	0.00024	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—liver cancer	1.81e-05	0.00024	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—HMOX1—liver cancer	1.8e-05	0.000239	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—MYC—liver cancer	1.79e-05	0.000238	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HPGDS—liver cancer	1.79e-05	0.000237	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—MYC—liver cancer	1.78e-05	0.000236	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARA—liver cancer	1.78e-05	0.000236	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CD—liver cancer	1.76e-05	0.000234	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	1.76e-05	0.000234	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.76e-05	0.000233	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—IL6—liver cancer	1.75e-05	0.000232	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ALB—liver cancer	1.74e-05	0.000231	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—liver cancer	1.74e-05	0.00023	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—MYC—liver cancer	1.72e-05	0.000228	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTP1—liver cancer	1.72e-05	0.000227	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—HMOX1—liver cancer	1.69e-05	0.000224	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—liver cancer	1.69e-05	0.000224	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.68e-05	0.000223	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—liver cancer	1.68e-05	0.000222	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	1.67e-05	0.000222	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—liver cancer	1.65e-05	0.000219	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—liver cancer	1.62e-05	0.000215	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—MYC—liver cancer	1.6e-05	0.000213	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—liver cancer	1.6e-05	0.000213	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1A1—liver cancer	1.6e-05	0.000212	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMA4—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PSMD10—liver cancer	1.6e-05	0.000211	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—MYC—liver cancer	1.59e-05	0.000211	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1A1—liver cancer	1.59e-05	0.000211	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—liver cancer	1.58e-05	0.000209	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GOT2—liver cancer	1.55e-05	0.000206	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—liver cancer	1.55e-05	0.000206	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—MYC—liver cancer	1.54e-05	0.000204	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CB—liver cancer	1.54e-05	0.000204	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—liver cancer	1.54e-05	0.000204	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND1—liver cancer	1.53e-05	0.000203	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CG—liver cancer	1.52e-05	0.000202	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—liver cancer	1.52e-05	0.000201	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TGFB1—liver cancer	1.52e-05	0.000201	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1A1—liver cancer	1.49e-05	0.000198	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—liver cancer	1.49e-05	0.000198	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—liver cancer	1.48e-05	0.000197	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1A—liver cancer	1.48e-05	0.000196	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	1.47e-05	0.000195	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PPARG—liver cancer	1.47e-05	0.000195	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND1—liver cancer	1.47e-05	0.000194	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARA—liver cancer	1.46e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP2E1—liver cancer	1.46e-05	0.000193	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARA—liver cancer	1.45e-05	0.000193	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	1.44e-05	0.000191	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—liver cancer	1.43e-05	0.00019	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1A—liver cancer	1.42e-05	0.000188	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—liver cancer	1.41e-05	0.000188	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—UGDH—liver cancer	1.41e-05	0.000188	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—liver cancer	1.39e-05	0.000185	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—liver cancer	1.37e-05	0.000182	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND1—liver cancer	1.37e-05	0.000181	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARA—liver cancer	1.37e-05	0.000181	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYCS—liver cancer	1.36e-05	0.000181	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	1.36e-05	0.000181	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GOT1—liver cancer	1.34e-05	0.000178	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GGT1—liver cancer	1.34e-05	0.000178	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CD—liver cancer	1.34e-05	0.000177	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EPT1—liver cancer	1.33e-05	0.000176	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1A—liver cancer	1.32e-05	0.000176	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ALB—liver cancer	1.32e-05	0.000175	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—liver cancer	1.32e-05	0.000175	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND1—liver cancer	1.31e-05	0.000174	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—liver cancer	1.31e-05	0.000174	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1A—liver cancer	1.27e-05	0.000168	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—liver cancer	1.26e-05	0.000168	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TAT—liver cancer	1.26e-05	0.000167	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CG—liver cancer	1.25e-05	0.000166	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CG—liver cancer	1.25e-05	0.000165	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—liver cancer	1.24e-05	0.000164	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—MYC—liver cancer	1.23e-05	0.000163	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	1.22e-05	0.000161	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PPARG—liver cancer	1.21e-05	0.00016	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTP1—liver cancer	1.2e-05	0.00016	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PPARG—liver cancer	1.2e-05	0.000159	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—HMOX1—liver cancer	1.19e-05	0.000157	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—MYC—liver cancer	1.18e-05	0.000156	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CG—liver cancer	1.17e-05	0.000155	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CB—liver cancer	1.17e-05	0.000155	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PPARG—liver cancer	1.13e-05	0.00015	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—liver cancer	1.11e-05	0.000147	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CD—liver cancer	1.1e-05	0.000146	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—MYC—liver cancer	1.1e-05	0.000146	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CD—liver cancer	1.09e-05	0.000145	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ALB—liver cancer	1.09e-05	0.000144	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ALB—liver cancer	1.08e-05	0.000143	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	1.07e-05	0.000142	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—MYC—liver cancer	1.05e-05	0.000139	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1A1—liver cancer	1.05e-05	0.000139	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CD—liver cancer	1.03e-05	0.000136	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ALB—liver cancer	1.02e-05	0.000135	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	9.79e-06	0.00013	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—liver cancer	9.77e-06	0.00013	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	9.6e-06	0.000127	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CB—liver cancer	9.6e-06	0.000127	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARA—liver cancer	9.59e-06	0.000127	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CB—liver cancer	9.54e-06	0.000127	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—liver cancer	9.38e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	9.34e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	9.32e-06	0.000124	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	9.25e-06	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	9.04e-06	0.00012	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—liver cancer	9.01e-06	0.00012	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	8.99e-06	0.000119	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CB—liver cancer	8.97e-06	0.000119	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	8.82e-06	0.000117	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—liver cancer	8.63e-06	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GLUL—liver cancer	8.57e-06	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CPT1B—liver cancer	8.57e-06	0.000114	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NR1H4—liver cancer	8.26e-06	0.00011	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CG—liver cancer	8.21e-06	0.000109	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	8.15e-06	0.000108	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA3—liver cancer	8.12e-06	0.000108	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PPARG—liver cancer	7.92e-06	0.000105	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.82e-06	0.000104	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—liver cancer	7.66e-06	0.000102	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.49e-06	9.94e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.48e-06	9.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA4—liver cancer	7.43e-06	9.85e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA2—liver cancer	7.24e-06	9.6e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CD—liver cancer	7.22e-06	9.57e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ALB—liver cancer	7.12e-06	9.45e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—liver cancer	7.11e-06	9.42e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTA1—liver cancer	6.99e-06	9.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	6.98e-06	9.26e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.93e-06	9.18e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NAT2—liver cancer	6.91e-06	9.16e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALDOB—liver cancer	6.62e-06	8.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.36e-06	8.44e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CRABP1—liver cancer	6.32e-06	8.38e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	6.31e-06	8.37e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CB—liver cancer	6.29e-06	8.34e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.16e-06	8.16e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—liver cancer	5.85e-06	7.76e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—liver cancer	5.82e-06	7.71e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—liver cancer	5.81e-06	7.7e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HPGDS—liver cancer	5.52e-06	7.32e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—liver cancer	5.47e-06	7.25e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.2e-06	6.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMD10—liver cancer	4.92e-06	6.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PSMA4—liver cancer	4.92e-06	6.53e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GOT2—liver cancer	4.79e-06	6.35e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—liver cancer	4.78e-06	6.34e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—liver cancer	4.75e-06	6.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.69e-06	6.22e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP2E1—liver cancer	4.5e-06	5.97e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—liver cancer	4.47e-06	5.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.24e-06	5.63e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYCS—liver cancer	4.21e-06	5.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GGT1—liver cancer	4.13e-06	5.48e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GOT1—liver cancer	4.13e-06	5.48e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—liver cancer	3.83e-06	5.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTP1—liver cancer	3.71e-06	4.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—HMOX1—liver cancer	3.66e-06	4.85e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—liver cancer	3.41e-06	4.52e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1A1—liver cancer	3.23e-06	4.29e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—liver cancer	3.13e-06	4.15e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—liver cancer	3.01e-06	4e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARA—liver cancer	2.96e-06	3.92e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CG—liver cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PPARG—liver cancer	2.44e-06	3.24e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CD—liver cancer	2.23e-06	2.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ALB—liver cancer	2.2e-06	2.91e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CB—liver cancer	1.94e-06	2.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—liver cancer	1.18e-06	1.57e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—liver cancer	9.67e-07	1.28e-05	CbGpPWpGaD
